Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects
Open Access
- 22 August 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (8) , e0202666
Abstract
This study aims to estimate the relationship between non-alcoholic fatty liver disease (NAFLD) and measures of atherosclerotic cardiovascular disease (ASCVD), and to determine to what extent such relationships are modified by metabolic risk factors. The study was conducted in the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS) pilot cohort (n = 1015, age 50–64 years, 51.2% women). NAFLD was defined as computed tomography liver attenuation ≤40 Hounsfield Units, excluding other causes of liver fat. Coronary artery calcification score (CACS) was assessed using the Agatston method. Carotid plaques and intima media thickness (IMT) were measured by ultrasound. Metabolic status was based on assessments of glucose homeostasis, serum lipids, blood pressure and inflammation. A propensity score model was used to balance NAFLD and non NAFLD groups with regards to potential confounders and associations between NAFLD status and ASCVD variables in relation to metabolic status were examined by logistic and generalized linear regression models. NAFLD was present in 106 (10.4%) of the subjects and strongly associated with obesity-related traits. NAFLD was significantly associated with CACS after adjustment for confounders and metabolic risk factors (OR 1.77, 95% CI 1.07–2.94), but not with carotid plaques and IMT. The strongest association between NAFLD and CACS was observed in subjects with few metabolic risk factors (n = 612 [60% of all] subjects with 0–1 out of 7 predefined metabolic risk factors; OR 5.94, 95% CI 2.13–16.6). NAFLD was independently associated with coronary artery calcification but not with measures of carotid atherosclerosis in this cohort. The association between NAFLD and CACS was most prominent in the metabolically healthy subjects.Keywords
Funding Information
- Hjärt-Lungfonden (254002157)
- Vetenskapsrådet (254002165)
- Sahlgrenska Akademin (70290)
- Västra Götalandsregionen (70370)
This publication has 52 references indexed in Scilit:
- The role of hepatokines in metabolismNature Reviews Endocrinology, 2013
- Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: The Jackson Heart StudyAtherosclerosis, 2012
- Dyslipidemia in Patients with Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease, 2012
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndromeAtherosclerosis, 2009
- Comparison of CT Methods for Determining the Fat Content of the LiverAmerican Journal of Roentgenology, 2007
- The Alcohol Use Disorders Identification Test: An Update of Research FindingsAlcohol, Clinical and Experimental Research, 2007
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis.Journal of Clinical Investigation, 1994